Broad RTK-targeted therapy overcomes molecular heterogeneity-driven resistance to cetuximab via vectored immunoprophylaxis in colorectal cancer
- Resource Type
- Article
- Source
- In
Cancer Letters 1 November 2016 382(1):32-43 - Subject
- Language
- ISSN
- 0304-3835